Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Ascending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
76282-0710-67 76282-0710 Lanreotide acetate Lanreotide Acetate 90.0 mg/.3mL Hormonal Therapy Somatostatin Analog Subcutaneous June 1, 2022 Aug. 18, 2023 In Use
69656-0101-02 69656-0101 Rolapitant Varubi 90.0 mg/1 Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Oral Oct. 7, 2015 Oct. 31, 2021 No Longer Used
57894-0450-01 57894-0450 Teclistamab TECVAYLI 90.0 mg/mL Immunotherapy Monoclonal Antibody BCMA, CD3 Subcutaneous Oct. 25, 2022 In Use
69468-0151-04 69468-0151 Uridine Triacetate Vistogard 951.0 mg/g Ancillary Therapy Chemoprotective Antidote Oral March 1, 2016 In Use
69468-0151-10 69468-0151 Uridine Triacetate Vistogard 951.0 mg/g Ancillary Therapy Chemoprotective Antidote Oral March 1, 2016 In Use
69468-0151-20 69468-0151 Uridine Triacetate Vistogard 951.0 mg/g Ancillary Therapy Chemoprotective Antidote Oral March 1, 2016 In Use
00115-1261-01 00115-1261 Anastrozole Anastrozole Hormonal Therapy Aromatase Inhibitor Oral June 5, 2013 Aug. 26, 2013 No Longer Used
00115-1261-03 00115-1261 Anastrozole Anastrozole Hormonal Therapy Aromatase Inhibitor Oral June 5, 2013 Aug. 26, 2013 No Longer Used
00115-1261-08 00115-1261 Anastrozole Anastrozole Hormonal Therapy Aromatase Inhibitor Oral June 5, 2013 Aug. 26, 2013 No Longer Used
00115-1261-10 00115-1261 Anastrozole Anastrozole Hormonal Therapy Aromatase Inhibitor Oral June 5, 2013 Aug. 26, 2013 No Longer Used

Found 10,000 results in 16 milliseconds — Export these results